A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice
Authors:
- Thomas M. BuckholzTBThomas M. Buckholz
- Lucinda F. MilardoLMLucinda F. Milardo
- Michelle R. MaysMMMichelle R. Mays
- Astrid OrtizAOAstrid Ortiz
- Kevin J. LumbKLKevin J. Lumb
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (7) , 1916-1919
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- PYY(3–36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese MiceThe Journal of Nutrition, 2006
- Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake AdditivelyEndocrinology, 2005
- The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesityExpert Opinion on Investigational Drugs, 2005
- Enhancement of feeding suppression by PYY3-36 in rats with area postrema ablationsPeptides, 2004
- Effects of PYY[3–36] in rodent models of diabetes and obesityInternational Journal of Obesity, 2004
- Peptide YY3–36Inhibits Food Intake in Mice through a Melanocortin-4 Receptor-Independent MechanismEndocrinology, 2004
- Acute effects of PYY3–36 on food intake and hypothalamic neuropeptide expression in the mouseBiochemical and Biophysical Research Communications, 2003
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003
- Gut hormone PYY3-36 physiologically inhibits food intakeNature, 2002